NEW YORK (GenomeWeb News) — Diagnostics developer Med BioGene has received a CA$307,000 ($262,000) grant from the Canadian government to develop biomarkers to help physicians detect and manage cardiovascular disease, the company said Friday.
The grant came from the National Research Council Canada Industrial Assistance Program.
MBI, based in Vancouver, BC, said it is working with CVD patient samples provided by the University of Ottawa Heart Institute to confirm its biomarkers.